Core Insights - Apimeds Pharmaceuticals US, Inc. is expanding its ai² Future Labs program by collaborating with graduate students from the University of San Diego's Knauss School of Business [1] - The initiative aims to identify promising pharmaceutical assets that are essential for enhancing human health while also nurturing future business leaders in the biopharmaceutical sector [1] - Future Labs is a component of Apimeds' broader ai² innovation strategy [1]